Zacks Small Cap Research – BENF: F2Q25 Earnings Review: Improving Financial Performance; Pivoting to Growth – Go Health Pro
By Michael Kim NASDAQ:BENF READ THE FULL BENF RESEARCH REPORT After the market closed on 11/14/24, Beneficient (NASDAQ:BENF) reported F2Q25 (Sep) earnings results. On a GAAP basis, BENF reported net income of $0.03 per Class A diluted share for F2Q25 – the company’s second consecutive profitable quarter as a public company – versus a loss … Read more
